RxDoctor Payments Data

Ian Reed, DO

Family Medicine · Lafayette, INNPI 1003336561

Payments from drug & device makers

$757in general payments, 2019–2025

Across 44 payments — averaging $17.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$179
  • Novo Nordisk$135
  • Lilly USA, LLC$133
  • AstraZeneca$105
  • AbbVie$94
  • Exact Sciences$33
  • plus $79 from 5 others

What the payments were for

  • Food & beverage$757100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$757 in reported general payments places this provider in the 55th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$109,768
Medicare patients
214
Services billed
1,549

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide54$60,657
EliquisApixaban41$55,313
JardianceEmpagliflozin41$36,257
RybelsusSemaglutide15$21,289
TrulicityDulaglutide15$13,708
SymbicortBudesonide/Formoterol Fumarate17$3,953
Levothyroxine Sodium263$2,581
Tamsulosin Hcl104$2,475
Atorvastatin Calcium286$2,291
Bupropion XlBupropion Hcl97$2,114
Duloxetine Hcl53$2,059
Metoprolol Succinate163$2,055
Rosuvastatin Calcium154$1,672
Omeprazole132$1,671
Pantoprazole Sodium129$1,595

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$135$81,94669 claims
PfizerEliquis$179$55,31341 claims
Lilly USA, LLCTrulicity$133$13,70815 claims
AstraZenecaSymbicort$105$3,95317 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Lafayette

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →